Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia

Edgar Jost, Nicole do Ó, Stefan Wilop, James G. Herman, Rainhardt Osieka, Oliver Galm

Research output: Contribution to journalArticle

Abstract

We investigated the methylation status of the CCAAT/enhancer binding protein alpha (C/EBPα) promoter region near the transcription start site in acute myelogenous leukemia (AML). In hematopoietic tumor cell lines, CpG island hypermethylation of the proximal C/EBPα promoter region was associated with transcriptional silencing, and treatment with the demethylating agent 5-aza-2′-deoxycytidine resulted in C/EBPα reexpression and promoter demethylation. Aberrant methylation of the C/EBPα promoter region occurred in 10/80 diagnostic AML samples, and there was an inverse correlation between aberrant methylation of C/EBPα and the negative cell cycle regulator p15. Our results provide further evidence for epigenetic dysregulation of C/EBPα in AML.

Original languageEnglish (US)
Pages (from-to)443-449
Number of pages7
JournalLeukemia Research
Volume33
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

CCAAT-Enhancer-Binding Protein-alpha
DNA Methylation
Acute Myeloid Leukemia
Transcription Factors
Genetic Promoter Regions
Methylation
decitabine
CpG Islands
Transcription Initiation Site
Tumor Cell Line
Epigenomics
Cell Cycle

Keywords

  • Acute myelogenous leukemia
  • C/EBP
  • Cell cycle
  • DNA methylation
  • Epigenetics
  • Transcriptional silencing

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia. / Jost, Edgar; Ó, Nicole do; Wilop, Stefan; Herman, James G.; Osieka, Rainhardt; Galm, Oliver.

In: Leukemia Research, Vol. 33, No. 3, 03.2009, p. 443-449.

Research output: Contribution to journalArticle

Jost, Edgar ; Ó, Nicole do ; Wilop, Stefan ; Herman, James G. ; Osieka, Rainhardt ; Galm, Oliver. / Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia. In: Leukemia Research. 2009 ; Vol. 33, No. 3. pp. 443-449.
@article{9b9e2685748549c8ae059b28df4cd792,
title = "Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia",
abstract = "We investigated the methylation status of the CCAAT/enhancer binding protein alpha (C/EBPα) promoter region near the transcription start site in acute myelogenous leukemia (AML). In hematopoietic tumor cell lines, CpG island hypermethylation of the proximal C/EBPα promoter region was associated with transcriptional silencing, and treatment with the demethylating agent 5-aza-2′-deoxycytidine resulted in C/EBPα reexpression and promoter demethylation. Aberrant methylation of the C/EBPα promoter region occurred in 10/80 diagnostic AML samples, and there was an inverse correlation between aberrant methylation of C/EBPα and the negative cell cycle regulator p15. Our results provide further evidence for epigenetic dysregulation of C/EBPα in AML.",
keywords = "Acute myelogenous leukemia, C/EBP, Cell cycle, DNA methylation, Epigenetics, Transcriptional silencing",
author = "Edgar Jost and {\'O}, {Nicole do} and Stefan Wilop and Herman, {James G.} and Rainhardt Osieka and Oliver Galm",
year = "2009",
month = "3",
doi = "10.1016/j.leukres.2008.07.027",
language = "English (US)",
volume = "33",
pages = "443--449",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia

AU - Jost, Edgar

AU - Ó, Nicole do

AU - Wilop, Stefan

AU - Herman, James G.

AU - Osieka, Rainhardt

AU - Galm, Oliver

PY - 2009/3

Y1 - 2009/3

N2 - We investigated the methylation status of the CCAAT/enhancer binding protein alpha (C/EBPα) promoter region near the transcription start site in acute myelogenous leukemia (AML). In hematopoietic tumor cell lines, CpG island hypermethylation of the proximal C/EBPα promoter region was associated with transcriptional silencing, and treatment with the demethylating agent 5-aza-2′-deoxycytidine resulted in C/EBPα reexpression and promoter demethylation. Aberrant methylation of the C/EBPα promoter region occurred in 10/80 diagnostic AML samples, and there was an inverse correlation between aberrant methylation of C/EBPα and the negative cell cycle regulator p15. Our results provide further evidence for epigenetic dysregulation of C/EBPα in AML.

AB - We investigated the methylation status of the CCAAT/enhancer binding protein alpha (C/EBPα) promoter region near the transcription start site in acute myelogenous leukemia (AML). In hematopoietic tumor cell lines, CpG island hypermethylation of the proximal C/EBPα promoter region was associated with transcriptional silencing, and treatment with the demethylating agent 5-aza-2′-deoxycytidine resulted in C/EBPα reexpression and promoter demethylation. Aberrant methylation of the C/EBPα promoter region occurred in 10/80 diagnostic AML samples, and there was an inverse correlation between aberrant methylation of C/EBPα and the negative cell cycle regulator p15. Our results provide further evidence for epigenetic dysregulation of C/EBPα in AML.

KW - Acute myelogenous leukemia

KW - C/EBP

KW - Cell cycle

KW - DNA methylation

KW - Epigenetics

KW - Transcriptional silencing

UR - http://www.scopus.com/inward/record.url?scp=58549105082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549105082&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2008.07.027

DO - 10.1016/j.leukres.2008.07.027

M3 - Article

C2 - 18757096

AN - SCOPUS:58549105082

VL - 33

SP - 443

EP - 449

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 3

ER -